Integrated Neuromuscular Inhibition Versus Instrument Assisted Soft Tissue Mobilization in Chronic Back Pain
Unknown statusNot applicableNCT06116058
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
this study will be conducted to identify the difference between the effect of integrated neuromuscular inhibition technique and instrument assisted soft tissue mobilization on back pain, pain threshold, back rang of motion ,back proprioception and back disability in chronic non specific low back pain
Study details
- Official title
- Integrated Neuromuscular Inhibition Technique Versus Instrument Assisted Soft Tissue Mobilization in Patients With Chronic Non Specific Low Back Pain
- Conditions
- Chronic Non Specific Low Back Pain
- Interventions
- Other: Experimental: Group A: integrated neuromuscular inhibition technique
- Other: Experimental: Group B :Instrument assissted soft tissue mobilization
- Other: control group C conventional physical therapy
- Sponsor
- Cairo University
- Start date
- 2023-11-01
- Primary completion
- 2024-03-01
- Sex
- All
- Age range
- from 18 Years to 30 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 1\. The patient's age ranged from 18 to 30 years.(Geogre et al, 2021) 2. Patients with low back pain for more than 3 months (pain felt between T12 and the gluteal fold). 3\. Patient with chronic low back pain 4. Normal body mass index from 18 -25kg/m2. Exclusion Criteria: * The subjects will be excluded if they have any of the followings: 1. Lumbar discogenic lesions or any inflammatory arthritis, tumors, infection involving the lumbar spine. 2. Patients with decreased range of motion secondary to congenital anomalies, muscular contracture, or bony block. 3. Previous lumbar or hip surgery or trauma. 4. Any hip structural abnormality such as malformations, impingements and degeneration. 5. Patients With cognitive impairments that would limit their participation
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06116058